December 2014 | Ophthalmology Innovation Source

Cunningham: 2015 Could Be A Big Year For Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 020″] OIS Co-Chair Emmett Cunningham delivers a high altitude review of the much sought after “Year in Review” report he delivers at each event. In this review, Cunningham touched upon his hopes for the sector & OIS. Podcast Guest Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham joined Clarus Ventures…

Mark Forchette

Delphinus Medical Technologies

TearScience CEO & Co-Founder Willis Explains Dry Eye Disease’s Emergence

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 019″] TearScience CEO & Co-Founder Tim Willis discusses the emergence of dry eye disease and details how his company’s diagnostic and treatment for a source of the condition could help meet the increasing interest from physicians and patients. Podcast Guest Tim Willis Mr. Willis has more than 35 years of medical…

Visual Disorders In Space And How Ophthalmology Can Help

View PDF Presentation Presenter: Dorit B. Donoviel, PhD Dr. Donoviel oversees the diverse portfolio of science and technology research and development projects at NSBRI that address the challenges faced by humans in space. She leads the NSBRI Industry Forum and the SMARTCAP seed award program for commercialization of biomedical technologies co-developed for both space and…

WaveTec CEO Tom Frinzi Hints at Plans for Future

WaveTec CEO Tom Frinzi spoke to the ease of the deal that paired his company with Alcon, hints at plans for the future and explains how the Ophthalmology Innovation Summit aided the process of turning around the once troubled company. Speaking With: Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which…

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the Ora System’s potential. Also, Attias adds his insights on the fascinating joint venture between Alcon and Google to develop a next generation contact lens. Speaking With: Laurent Attias Laurent Attias…

Jeff George’s Vision for Innovation at Alcon

Jeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the company will pursue many opportunities in ophthalmology. Speaking With: Jeff George Jeff was appointed to lead Alcon in May 2014. As the global leader in eye care, Alcon provides innovative…

Q&A with Richard Lindstrom

First adopter Richard Lindstrom, MD, details the role new technology play in ophthalmology. Speaking With: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology, Associate Director: Minnesota Lions Eye Bank, Board Member: University of Minnesota Foundation, and…

Q&A with Michael Brownell

Michael Brownell, CEO of Gobiquity, explains how his company is turning smartphones into a critical diagonstic tool to treat pediatric vision. Speaking With: Michael Brownell Michael Brownell joined Gobiquity as CEO in 2012, with prior experience in a variety of leadership roles in ophthalmology and other industries. Gobiquity closed Series A financing with Interwest in…

How to Do M&A Well

Highlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved. View Full Profile Panelists: Jeff George Jeff was…

CEOs Share Lessons from IPOs

A panel of ophthalmology executives at the Ophthalmology Innovation Summit discuss the perks and pitfalls of going public. Moderator: David Guyer, MD Under Dr. Guyer’s leadership, Ophthotech raised more than $350 million in financing from May to September 2013, including a $192 million IPO, a multi-tranched $125 million royalty financing deal with Novo A/S and…

Google Eyes Ophthalmology

Google and Alcon executives shared the stage to answer some questions about thier unique partnership. Alcon executives Laurent Attias, Head, Global Commercial Strategy and Franck Leveiller, PhD, VP, Head of Research & Development Vision Care and Brian P. Otis, PhD, founder of the Smart Contact LensProject at Google X answered questions from OIS Co-Chair Gil…